NCT00985517 - Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 29, 2009

Primary Completion Date

November 9, 2014

Study Completion Date

November 16, 2017

Conditions

Idiopathic Parkinson's Disease

Interventions

BIOLOGICAL

CERE-120: Adeno-Associated Virus Delivery of Neurturin

PROCEDURE

Sham Surgery

Trial Locations (11)

University of Alabama at Birmingham, Birmingham

Stanford School of Medicine, Palo Alto

University of California, San Francisco, San Francisco

Emory University, Atlanta

Rush University Medical Center, Chicago

Beth Israel Medical Center, New York

Columbia University Medical Center, New York

Mount Sinai Medical Center, New York

Duke University, Durham

University of Pennsylvania, Philadelphia

Baylor College of Medicine, Houston